Re:How one woman made a ‘tricorder’ that could change medici...
by 100ideas on Wednesday December 09, 2015 @02:09PM
(#10705964)
Or... they could be chaining polymerases to tiny tuning-forks to tune the speed and fidelity of DNA replication... sounds pretty cool!
From a patent granted to Anita Goel / Nanobiosym: https://www.google.com/patents/US7494791
"Denaturation of double stranded nucleic acids, primer annealing, and precision control over primer extension by polymerase can be accomplished by applying stress to a nucleic acid. These methods can provide one ore more benefits over conventional PCR methods including: precision control over the PCR process; generally improved fidelity; improved accuracy over problematic... [etc etc]"
It may have to do with how much blood they need for each multiplex test. Clinical qPCR diagnostics need at least 5-10 uL of blood for each test (ballpark minimum). A finger prick or dried blood sample card [1] may provide enough DNA (human or pathogen depending on the test) for one or two of these tests, but not more. To run 100 or 1000 tests in parallel, a lab would need 5-50 mL of blood. Easy to get from a venous blood draw but not easy in the field.
So perhaps Nanobiosym is developing a reliable method purifying DNA from blood and running multiplex qPCR at nanoscale volumes, and possibly enriching the purified DNA first for particular pathogen DNA sequences with a non-qPCR method. The capability to run hundreds of qPCR-based diagnostic tests in parallel from a single finger prick of blood would result in significant improvements in clinical convenience and reagent cost-savings.
It's an interesting challenge: in a person who is HIV positive but hasn't presented with AIDS, how many viral genomes can be expected to be found on average in a single finger prick of blood (viral titer)? It could be on average only 0.001 - 1 genome [2]
[1] http://www.spotonsciences.com/dbstechnology/
[2] "If a subject has a high HIV viral load (for example, at least 1 ,000 copies/ml plasma), this may indicate treatment failure, i.e. that the virus is replicating and the disease may progress more quickly. If HIV viral load is low (for example, less than 1 ,000 copies/ml plasma), this indicates that the anti-viral treatment regimen is effective, i.e. that the virus may not be actively replicating and the disease may progress more slowly." - http://www.google.com/patents/WO2014140641A1?cl=en